Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01FQZ
|
||||
| Former ID |
DNC014341
|
||||
| Drug Name |
Erythribyssin O
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C21H18O5
|
||||
| Canonical SMILES |
CC(=CCC1=C(C=CC2=C1OC3=C2COC4=CC(=C(C=C43)C=O)O)O)C
|
||||
| InChI |
1S/C21H18O5/c1-11(2)3-4-14-17(23)6-5-13-16-10-25-19-8-18(24)12(9-22)7-15(19)21(16)26-20(13)14/h3,5-9,23-24H,4,10H2,1-2H3
|
||||
| InChIKey |
AGFXXWXSPAYWMF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||